Evidence map›Paper›PMID 23986399›Full record

ArticleScience translational medicine2013

Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48.

Elias Pavlopoulos, Sidonie Jones, Stylianos Kosmidis, Maggie Close, Carla Kim, Olga Kovalerchik, Scott A Small, Eric R Kandel

Abstract read
In one paragraph

Article in Science translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Taurine deficiency as a driver of aging.Science (New York, N.Y.) · 2023
    Article
  12. The consequences of sleep deprivation on cognitive performance.Neurosciences (Riyadh, Saudi Arabia) · 2023
    Review
  13. Review
  14. Article
  15. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Article
  18. Chromatin Remodeling in the Brain-aInternational journal of molecular sciences · 2021
    Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Elias PavlopoulosDepartment of Neuroscience, Columbia University, New York, NY 10032, USA.
Sidonie Jones
Stylianos Kosmidis
Maggie Close
Carla Kim
Olga Kovalerchik
Scott A Small
Eric R Kandel

Funding

Satellite Diagnostic and Treatment Clinic CoreP50AG008702 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI DE JAGER, PHILIP L · 1989 to 2019
$46.3M
MRI and mouse models of Alzheimer's disease and agingR01AG025161 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SMALL, SCOTT A · 2005 to 2015
$3.0M
Neural and Behavioral Profiles of Cognitive AgingR01AG034618 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SMALL, SCOTT A · 2009 to 2013
$1.8M
NIA NIH HHS P50 AG008702NIA NIH HHS R01 AG025161NIA NIH HHS R01 AG034618
6 · The paper itself

Abstract

To distinguish age-related memory loss more explicitly from Alzheimer's disease (AD), we have explored its molecular underpinning in the dentate gyrus (DG), a subregion of the hippocampal formation thought to be targeted by aging. We carried out a gene expression study in human postmortem tissue harvested from both DG and entorhinal cortex (EC), a neighboring subregion unaffected by aging and known to be the site of onset of AD. Using expression in the EC for normalization, we identified 17 genes that manifested reliable age-related changes in the DG. The most significant change was an age-related decline in RbAp48, a histone-binding protein that modifies histone acetylation. To test whether the RbAp48 decline could be responsible for age-related memory loss, we turned to mice and found that, consistent with humans, RbAp48 was less abundant in the DG of old than in young mice. We next generated a transgenic mouse that expressed a dominant-negative inhibitor of RbAp48 in the adult forebrain. Inhibition of RbAp48 in young mice caused hippocampus-dependent memory deficits similar to those associated with aging, as measured by novel object recognition and Morris water maze tests. Functional magnetic resonance imaging studies showed that within the hippocampal formation, dysfunction was selectively observed in the DG, and this corresponded to a regionally selective decrease in histone acetylation. Up-regulation of RbAp48 in the DG of aged wild-type mice ameliorated age-related hippocampus-based memory loss and age-related abnormalities in histone acetylation. Together, these findings show that the DG is a hippocampal subregion targeted by aging, and identify molecular mechanisms of cognitive aging that could serve as valid targets for therapeutic intervention.

Indexed as

AcetylationAdultAgedAged, 80 and overAgingAnimalsDentate GyrusFemaleGene Expression Regulation, DevelopmentalGenes, DominantHistone AcetyltransferasesHistonesHumansMaleMembrane ProteinsMemory DisordersHistone AcetyltransferasesHistonesMembrane ProteinsPag1 protein, mousePhosphoproteinsRBBP4 protein, humanRbbp4 protein, mouseRetinoblastoma-Binding Protein 4RNA, Messenger

Identifiers

PMID23986399
PMCPMC4940031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.